Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Astellas Pharma US, Medivation report results of advanced prostate cancer patient, caregiver survey

Astellas Pharma US, Inc. and Medivation, Inc. today announced results of a national survey of men with advanced prostate cancer and caregivers of men with advanced prostate cancer.

26 Sep 2013

University of Michigan offers new test to improve PSA screening for prostate cancer

More than 1 million men will undergo a prostate biopsy this year, but only about one-fifth of those biopsies will result in a cancer diagnosis.

26 Sep 2013

Researchers identify existence of precursor cells in early prostate cancers

A team of cancer researchers at the University of California, San Diego has identified the existence of precursor cells in early prostate cancers. These cells are resistant to androgen-deprivation therapy, and may drive the subsequent emergence of recurrent or metastatic prostate cancer.

26 Sep 2013

Drug to treat metastatic castration-resistant prostate cancer delays progression of pain and quality of life deterioration in men

Abiraterone acetate, a recently FDA-approved drug used to treat men with metastatic castration-resistant prostate cancer, significantly delays progression of pain and quality of life deterioration when taken in conjunction with prednisone.

25 Sep 2013

Guideline focuses on radiation therapy to be highlighted during ASTRO's 55th Annual Meeting

The American Society for Radiation Oncology will highlight the recently published Adjuvant and Salvage Radiotherapy After Prostatectomy: ASTRO/AUA Guideline during ASTRO's 55th Annual Meeting, September 22-25, 2013, in Atlanta.

24 Sep 2013

Long-term hormonal therapy has no additional benefits in men with intermediate-risk prostate cancer

A secondary analysis of the historic RTOG 9202 prostate cancer trial examined results of men with intermediate-risk prostate cancer who had received long-term hormonal therapy after radiation therapy, and concluded that there were no additional benefits when compared to short-term hormonal therapy, according to research presented today at the American Society for Radiation Oncology's (ASTRO's) 55th Annual Meeting.

24 Sep 2013

TAS therapy prior to radiation therapy yields favorable outcomes in PCa patients

A shorter course of androgen suppression therapy prior to radiation therapy, when compared to a longer course of androgen suppression therapy, yields favorable outcomes and fewer adverse effects for intermediate-risk prostate cancer patients, according to research presented today at the American Society for Radiation Oncology's (ASTRO) 55th Annual Meeting.

24 Sep 2013

Applied Integrin Sciences' drug candidate eliminates ovarian cancer tumors in pre-clinical study

Applied Integrin Sciences, Inc. announced today that its first cancer therapeutic drug candidate eliminated all intraperitoneal ovarian cancer tumors in a pre-clinical study testing a novel treatment regimen.

21 Sep 2013

Researchers make new breakthroughs in brain circuitry controlling fertility

In a landmark discovery, the final piece in the puzzle of understanding how the brain circuitry vital to normal fertility in humans and other mammals operates has been put together by researchers at New Zealand's University of Otago.

21 Sep 2013

CHMP recommends approval of Xofigo for CRPC, symptomatic bone and visceral metastases

Bayer HealthCare announced today that the the European Committee for Medicinal Products for Human Use recommended Xofigo (radium Ra 223 dichloride) for approval with a proposed indication for the treatment of adults with castration-resistant prostate cancer, symptomatic bone metastases and no known visceral metastases.

20 Sep 2013

EDCs pose threat to human health, say endocrine experts

In an editorial published in Endocrinology, a journal of The Endocrine Society, endocrine experts agreed that endocrine-disrupting chemicals pose a threat to human health and to the ecosystems of the earth.

20 Sep 2013

Clinical trial by Moffitt to reduce risk of prostate cancer in black men

Prostate cancer kills more African-American and black men than any other group. Yet, according to a new review published by Moffitt Cancer Center researchers, there is a significant lack of clear and consistent screening and early detection guidelines or prevention strategies.

20 Sep 2013

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Astellas Pharma US, Medivation report results of advanced prostate cancer patient, caregiver survey

University of Michigan offers new test to improve PSA screening for prostate cancer

Researchers identify existence of precursor cells in early prostate cancers

Drug to treat metastatic castration-resistant prostate cancer delays progression of pain and quality of life deterioration in men

Guideline focuses on radiation therapy to be highlighted during ASTRO's 55th Annual Meeting

Long-term hormonal therapy has no additional benefits in men with intermediate-risk prostate cancer

TAS therapy prior to radiation therapy yields favorable outcomes in PCa patients

Applied Integrin Sciences' drug candidate eliminates ovarian cancer tumors in pre-clinical study

Researchers make new breakthroughs in brain circuitry controlling fertility

CHMP recommends approval of Xofigo for CRPC, symptomatic bone and visceral metastases

EDCs pose threat to human health, say endocrine experts

Clinical trial by Moffitt to reduce risk of prostate cancer in black men

Comprehensive changes in lifestyle could reverse ageing

Dendreon Gets Green Light In Europe

Improve Your Lifestyle, Lengthen Your Telomeres

Dendreon Gets Greenlight In Europe

Inside Jersey magazine names Rutgers Cancer Institute of New Jersey physicians among Top Doctors

Study shows that changes in diet, lifestyle choices may result in longer telomeres

Gene panel predicts low-risk prostate cancer fate

Bruker Launches Second Phase Of SISCAPA-MALDI Collaboration

What to know about prostate cancer eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

What to know about prostate cancer eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Newsletters you may be interested in